Media - Press Articles
With the recent news that Alba Bioscience has gained clearance to market its products in the US, Laboratory News profiles the rapid rise of the Scottish-based diagnostics company
Approval by American watchdogs for an Edinburgh based company's 15 ready-to-use reagents will pave the way to new world markets in the blood transfusion field.
DIRECTORS at Edinburgh biotech firm Alba Bioscience will jet out to two further key global conferences next month as the firm looks to build on growing interest in its product portfolio.
City-based firm gets green light to supply products to America
Alba Bioscience has won clearance to supply products to the US market.
The Food and Drug Administration today licensed 15 new blood grouping reagents that previously were unavailable in the United States.
Alba Bioscience, the commercial arm of the Scottish National Blood Transfusion Service has been bought by the Cambridge firm Quotient BioResearch...
Alba Bioscience, the commercial arm of the Scottish National Blood Transfusion Service has been bought by the Cambridge firm Quotient BioResearch for an undisclosed sum.
Newly-branded Alba Bioscience is in advanced talks with the North American Food & Drug Administration (FDA) over its plan to make big sales push into the United States and build on an annualised 30 per cent growth.
|